There is still controversy over the impact of @entity6 control and duration on bone mass and growth parameters in @entity1 and adolescents with @entity1723 ( @entity1723 ). The aim of this study was to assess @entity79 ( @entity79 ) at axial and appendicular sites, in @entity1 with noncomplicated @entity1723 of recent onset, and its relation to metabolic control and auxological parameters (weight, height, and puberal stage). Fifty-five young Spanish @entity1723 , otherwise healthy @entity1 (26 males, aged (SD 9.7 +/- 4.3 years) and 29 females, aged (SD 11.2 +/- 3.8 years) were studied. Duration of @entity6 was 1-13.8 years. Two hundred eighty-two age-matched, healthy, Spanish @entity1 served as controls. @entity4051 was assayed by high pressure liquid chromatography (HPLC) and @entity79 was measured using dual X-ray absorptiometry (DXA) densitometry at the spine and forearm. Results showed a Gaussian @entity79 distribution of @entity1 according to sex and age, without @entity458 differences. There was no correlation between @entity79 and glycated hemoglobin (average life disease or last @entity4051 values) or duration of the disease; moreover, no differences in bone mass were found between <3 and >/=3 years of disease duration. @entity6 impact index (mean @entity4051 x duration of disease in months) showed no significant influence of @entity6 control on @entity79 . We could not demonstrate any impact of @entity6 on @entity79 and growth parameters in @entity1 with @entity1723 of short duration.

Bone mineral density in XXXX and adolescents with @entity6 of recent onset.

@entity1 :: ('9606', 'Species') :: ['children', 'patients'] @entity4051 :: ('3039', 'Gene') :: ['HbA1'] @entity6 :: ('MESH:D003920', 'Disease') :: ['Diabetes', 'diabetes'] @entity458 :: ('MESH:D020018', 'Disease') :: ['sexual-stage'] @entity79 :: ('MESH:D001847', 'Disease') :: ['bone mineral density', 'BMD'] @entity1723 :: ('MESH:D003922', 'Disease') :: ['IDDM', 'insulin-dependent diabetes mellitus']
@entity1 :: (9606,Species) :: ['children']
